However, siRNA mediated knock-down of Usp9X in glioblastoma cells recapitulates the effects of WP1130, suggesting that WP1130 significantly mediates its anti-glioma effects by interference with Usp9X function. This evidence concerns the gene USP9X and central nervous system cancer.